Show
Sort by
-
Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease
-
- Conference Paper
- C3
- open access
Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in non-alcoholic fatty liver disease
-
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
-
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice
-
Anti-placental growth factor therapy attenuates experimental hepatopulmonary syndrome
-
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model
-
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
-
Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice
-
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
-
- Conference Paper
- C3
- open access
Angiogenic changes in a new mouse model for hepatocellular carcinoma